The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients

키워드

참고문헌 (35)

1. Bulut M, "Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder", J Affect Disord, 150, pp.829~833 (2013)[DOI]
2. Camkurt MA, "Depression in pregnancy is associated with decreased glutathione peroxidase activity in fetal cord blood", J Psychiatr Res, 79, pp.57~60 (2016)[DOI]
3. Jin-Sung Park, "Lack of Association between Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphisms and Generalized Social Anxiety Disorder in Korean Population", Clinical Psychopharmacology and Neuroscience, 9(3), pp.129~133 (2011), 대한정신약물학회
4. Wittchen HU, "Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey", Int Clin Psychopharmacol, 15, pp.319~328 (2000)[DOI]
5. Biomarkers Definitions Working Group, "Biomarkers and surrogate endpoints: preferred definitions and conceptual framework", Clin Pharmacol Ther, 69, pp.89~95 (2001)[DOI]
6. Milawaty Nurjono, "A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia", Clinical Psychopharmacology and Neuroscience, 10(2), pp.61~70 (2012), 대한정신약물학회[DOI]
7. Suk Ling Ma, "Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer’s Disease", Clinical Psychopharmacology and Neuroscience, 9(2), pp.54~66 (2011), 대한정신약물학회
8. Mehmet Akif Camkurt, "Investigation of Dysregulation of Several MicroRNAs in Peripheral Blood of Schizophrenia Patients", Clinical Psychopharmacology and Neuroscience, 14(3), pp.256~260 (2016), 대한정신약물학회
9. Md. Mamun Al-Amin, "Effects of Antipsychotics on the Inflammatory Response System of Patients with Schizophrenia in Peripheral Blood Mononuclear Cell Cultures", Clinical Psychopharmacology and Neuroscience, 11(3), pp.144~151 (2013), 대한정신약물학회
10. Steiger A, "Wake and sleep EEG provide biomarkers in depression", J Psychiatr Res, 44, pp.242~252 (2010)[DOI]
11. Camkurt MA, "Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naive, first episode, non-smoker major depression patients and healthy controls", Psychiatry Res, 238, pp.81~85 (2016)[DOI]
12. Gunes M, "Diagnostic performance of increased prolidase activity in schizophrenia", Neurosci Lett, 613, pp.36~40 (2016)[DOI]
13. Selek S, "Prolidase activity and its diagnostic performance in bipolar disorder", J Affect Disord, 129, pp.84~86 (2011)[DOI]
14. Selek S, "Oxidative markers of myeloperoxidase and catalase and their diagnostic performance in bipolar disorder", J Affect Disord, 181, pp.92~95 (2015)[DOI]
15. de Oliveira MR, "Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses", Neurotoxicology, 28, pp.1191~1199 (2007)[DOI]
16. Desrumaux C, "Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice", FASEB J, 19, pp.296~297 (2005)[DOI]
17. Hovatta I, "Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice", Nature, 438, pp.662~666 (2005)[DOI]
18. Lopresti AL, "A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers", Prog Neuropsychopharmacol Biol Psychiatry, 48, pp.102~111 (2014)[DOI]
19. Grignon S, "Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.365~369 (2007)[DOI]
20. Tezcan E, "Free radicals in patients with post-traumatic stress disorder", Eur Arch Psychiatry Clin Neurosci, 253, pp.89~91 (2003)
21. Atmaca M, "Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment", Eur Arch Psychiatry Clin Neurosci, 254, pp.231~235 (2004)
22. Atmaca M, "Antioxidant enzyme and malondialdehyde levels in patients with social phobia", Psychiatry Res, 159, pp.95~100 (2008)[DOI]
23. Beutler E, "Red cell metabolism: a manual of biochemical methods" (1984), Grune & Stratton
24. Fridovich I, "Superoxide radical and superoxide dismutases", Acc Chem Res, 5, pp.321~326 (1972)[DOI]
25. Ohkawa H, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction", Anal Biochem, 95, pp.351~358 (1979)[DOI]
26. Kuloglu M, "Antioxidant enzyme and malondialdehyde levels in patients with panic disorder", Neuropsychobiology, 46, pp.186~189 (2002)[DOI]
27. Kuloglu M, "Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder", Neuropsychobiology, 46, pp.27~32 (2002)[DOI]
28. Ng F, "Oxidative stress in psychiatric disorders: evidence base and therapeutic implications", Int J Neuropsychopharmacol, 11, pp.851~876 (2008)
29. Perry JJ, "The structural biochemistry of the superoxide dismutases", Biochim Biophys Acta, 1804, pp.245~262 (2010)[DOI]
30. Bilici M, "Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments", J Affect Disord, 64, pp.43~51 (2001)[DOI]
31. Herken H, "Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment", Arch Med Res, 38, pp.247~252 (2007)[DOI]
32. Bajpai A, "Oxidative stress and major depression", J Clin Diagn Res, 8, pp.CC04~CC07 (2014)
33. Alpak G, "High catalase and low thiol levels in adult-ADHD patients", Klinik Psikofarmakoloji Bulteni-Bull Clin Psychopharmacol, 24, pp.128~134 (2014)[DOI]
34. Taylor R, "Interpretation of the correlation coefficient: a basic review", J Diag Med Sonography, 6, pp.35~39 (1990)[DOI]
35. Kim JW, "Diagnostic utility of quantitative EEG in un-medicated schizophrenia", Neurosci Lett, 589, pp.126~131 (2015)[DOI]

관련 논문AI추천